Last reviewed · How we verify

NCT04606186

Influence of Probiotics on Clinical Parameters, the Oral Microbiome and the Immune System During an Orthodontic Treatment in Adult Patients

Status unknown NA Last updated 18 May 2022
What this trial tests

NA trial testing Lactobacillus reuteri Prodentis®-lozenges (DSM 17938, ATCC PTA 5289) in Gingivitis in 34 participants. Status unknown.

Timeline
19 October 2020
Primary endpoint
1 November 2023
1 November 2023

Quick facts

Lead sponsorUniversity of Erlangen-Nürnberg
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposeprevention
Enrollment34
Start date19 October 2020
Primary completion1 November 2023
Estimated completion1 November 2023
Sites1 location across Germany

Drugs / interventions tested

Conditions studied

Sponsor

University of Erlangen-Nürnberg

Who can join

18 and older, any sex, with Gingivitis or Periodontal Inflammation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Orthodontic treatment with fixed appliances can be necessary to correct malocclusions in adolescence or adulthood. It its known that orthodontic treatment induces aseptic pseudo-inflammatory reactions. However, studies could show that an increase of certain inflammatory cytokines during orthodontic treatment correlated with a higher risk of root resorption. Moreover, it has been shown that orthodontic treatment leads to a dysbiosis of the oral microbiome especially during the first 3 months of the orthodontic treatment. This could be a potential risk factor as the inflammation of periodontitis during an orthodontic treatment could favor root resorption and progressive destruction of the periodontal apparatus. Probiotics are already used successfully as an adjuvant therapy in the treatment of periodontitis to improve clinical parameters and to reduce local inflammation. However, there are only a few studies that investigated the influence of probiotics during an orthodontic treatment. Therefore, the aim of our study is to investigate if the daily intake of lozenges containing probiotics versus placebo lozenges during the first 3 months of orthodontic treatment with fixed appliances can improve clinical parameters, reduce local inflammation, systemic inflammation and prevent a dysbiosis of the oral microbiome.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Influence of probiotics on the periodontium, the oral microbiota and the immune response during orthodontic treatment in adolescent and adult patients (ProMB Trial): study protocol for a prospective, double-blind, controlled, randomized clinical trial.
    Seidel CL, Gerlach RG, Weider M, Wölfel T, et al · · 2022 · cited 12× · PMID 35477563 · DOI 10.1186/s12903-022-02180-8

Verify or expand the search:

Other trials of Lactobacillus reuteri Prodentis®-lozenges (DSM 17938, ATCC PTA 5289)

Trials testing the same drug.

Other recruiting trials for Gingivitis

Currently open trials in the same condition.

Other University of Erlangen-Nürnberg trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04606186.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing